Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04188145 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer

Study acronym: BEVAMAINT
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Sep 2023 to Sep 2029 Trial status: Recruiting to Active, Not Recruiting · Completion date: Dec 2025 to Sep 2029 · Site details revisedv3 Show 3 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Completion date: Dec 2025 to Sep 2029
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Dec 2019 to Jan 27, 2020 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Dec 2019 to Jan 27, 2020
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of BEVAMAINT is to improve benefic effect of maintenance therapy after a first line of induction chemotherapy for patients with colorectal cancer
Trial Details
NCT Number NCT04188145
Lead Sponsor Centre Hospitalier Universitaire Dijon
Conditions Metastatic Colorectal Cancer
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov